The pneumococcal conjugate vaccine (PCV13) offers no clinical benefits for adults, instead increasing pneumonia and hospitalization risks, particularly in vulnerable subgroups.
The pneumococcal conjugate vaccine (PCV13) offers no clinical benefits for adults, instead increasing pneumonia and hospitalization risks, particularly in vulnerable subgroups.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
